Andon Health Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000Q84
CNY
76.13
-2.17 (-2.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,364.92
2,588.08
3,189.22
26,312.44
2,393.15
2,002.83
704.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,364.92
2,588.08
3,189.22
26,312.44
2,393.15
2,002.83
704.13
Raw Material Cost
538.18
809.16
1,238.23
5,448.28
952.23
940.37
566.74
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
117.61
69.42
15.23
6.73
17.16
9.60
10.49
Selling and Distribution Expenses
810.99
819.06
806.25
1,596.49
457.92
549.51
237.74
Other Expenses
19.37
18.01
24.85
24.02
3.18
4.91
4.91
Total Expenditure (Excl Depreciation)
1,660.49
1,877.72
2,308.17
7,291.73
1,459.12
1,548.62
864.05
Operating Profit (PBDIT) excl Other Income
-295.59999999999997
710.4000000000001
881
19020.7
934
454.20000000000005
-159.9
Other Income
862.92
792.94
746.70
254.48
68.37
317.77
14.71
Operating Profit (PBDIT)
617.10
1,535.48
1,603.83
18,894.17
1,084.66
825.83
-118.91
Interest
117.61
69.42
15.23
6.73
17.16
9.60
10.49
Exceptional Items
2,109.82
710.90
101.04
-485.31
30.49
-483.55
219.60
Gross Profit (PBDT)
826.74
1,778.91
1,950.99
20,864.16
1,440.92
1,062.45
137.39
Depreciation
81.14
68.10
107.62
143.00
96.97
92.59
71.73
Profit Before Tax
2,528.17
2,108.86
1,582.02
18,259.12
1,001.01
240.08
18.47
Tax
257.75
306.83
231.11
1,773.76
65.23
2.92
-8.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,266.75
1,668.73
1,251.61
16,030.17
908.64
242.33
66.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,266.75
1,668.73
1,251.61
16,030.17
908.64
242.33
66.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.76
131.31
97.62
453.93
25.76
-5.50
-39.39
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,269.50
1,800.04
1,349.23
16,484.09
934.40
236.83
27.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
21,832.16
20,736.50
19,229.37
19,554.22
2,872.58
1,884.76
1,662.53
Earnings per share (EPS)
5.21
3.78
2.77
34.3
2.0
0.56
0.15
Diluted Earnings per share
5.21
3.78
2.77
34.3
2.0
0.56
0.15
Operating Profit Margin (Excl OI)
-23.95%
26.06%
23.5%
70.3%
38.41%
20.74%
-29.16%
Gross Profit Margin
191.17%
84.11%
52.98%
69.94%
45.88%
16.61%
12.81%
PAT Margin
166.07%
64.48%
39.25%
60.92%
37.97%
12.1%
9.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -47.26% vs -18.85% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 26.08% vs 33.41% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -133.10% vs -13.37% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 69.45% vs 356.58% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Andon Health Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,364.92
0
1,364.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,364.92
0
1,364.92
Raw Material Cost
538.18
0
538.18
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
117.61
0
117.61
Selling and Distribution Expenses
810.99
0
810.99
Other Expenses
19.37
0.00
19.37
Total Expenditure (Excl Depreciation)
1,660.49
0
1,660.49
Operating Profit (PBDIT) excl Other Income
-295.57
0.00
-295.57
Other Income
862.92
0
862.92
Operating Profit (PBDIT)
617.10
0
617.10
Interest
117.61
0
117.61
Exceptional Items
2,109.82
0
2,109.82
Gross Profit (PBDT)
826.74
0
826.74
Depreciation
81.14
0
81.14
Profit Before Tax
2,528.17
0
2,528.17
Tax
257.75
0
257.75
Provisions and contingencies
0
0
0.00
Profit After Tax
2,266.75
0
2,266.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,266.75
0
2,266.75
Share in Profit of Associates
0
0
0.00
Minority Interest
2.76
0
2.76
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,269.50
0
2,269.50
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
21,832.16
0
21,832.16
Earnings per share (EPS)
5.21
0
5.21
Diluted Earnings per share
5.21
0
5.21
Operating Profit Margin (Excl OI)
-23.95%
0%
0.00
-23.95%
Gross Profit Margin
191.17%
0%
0.00
191.17%
PAT Margin
166.07%
0%
0.00
166.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 136.49 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -47.26% vs -18.85% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 226.95 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 26.08% vs 33.41% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -24.58 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -133.10% vs -13.37% in Dec 2024

Annual - Interest
Interest 11.76 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 69.45% vs 356.58% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -23.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024